查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2148901

糖尿病醫療設備市場：規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測

Diabetes Devices Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

糖尿病醫療設備市場的成長要素

全球糖尿病醫療設備市場預計在2025年達到357.1億美元，2026年成長至387.7億美元，2034年達到747.3億美元，預測期內複合年成長率（CAGR）為8.55%。北美地區在2025年佔據市場主導地位，市佔率達40.54%。推動該市場成長的主要因素包括糖尿病盛行率上升、對持續疾病管理的需求不斷成長、技術進步以及互聯監測和胰島素輸註解決方案的日益普及。

糖尿病醫療設備市場涵蓋了監測和治療技術，旨在幫助患者和醫療專業人員更有效地管理糖尿病。血糖值監測系統、持續血糖監測設備、胰島素幫浦、胰島素筆和自動給藥系統正日益成為現代糖尿病照護的重要組成部分。從常規監測向持續、互聯和個人化管理的轉變，為市場擴張創造了新的機會。

市場定義和範圍

糖尿病醫療設備市場涵蓋用於長期監測、診斷、治療和管理糖尿病的醫療設備。此市場按類型、分銷管道和地區進行分析。預計到2034年，醫療保健支出不斷成長、診斷技術不斷進步、保險覆蓋範圍不斷擴大以及人們對糖尿病管理的認知不斷提高，將推動市場成長。

市場動態

促進因素

糖尿病盛行率不斷上升

全球糖尿病盛行率的上升是推動血糖監測和治療設備需求成長的主要因素。快速的都市化、久坐的生活方式、肥胖以及飲食習慣的改變都加劇了糖尿病患者人數的增加。因此，診斷率的提高也帶動了對血糖值監測系統和胰島素輸注技術的需求。

先進產品介紹

持續創新正在改變糖尿病的管理方式。連網血糖監測儀、智慧胰島素幫浦、穿戴式裝置、胰島素貼片和自動胰島素輸注平台正在提高患者的便利性和治療效果。與行動應用程式和數位健康平台的整合進一步加速了這些產品的普及應用。

趨勢

市場正朝著數位化、自動化和互聯互通的糖尿病照護方向發展。持續血糖監測正成為一項關鍵技術，因為它能夠實現頻繁的血糖值測量，使患者和醫護人員能夠隨時了解血糖變化趨勢。人工智慧、預測分析、雲端連接和行動應用程式正擴大整合到糖尿病設備中，從而支援個人化、數據驅動的治療。

阻礙因素

高昂的研發成本、嚴格的監管要求、保險報銷限制以及複雜的生產流程都可能阻礙市場擴張。此外，先進醫療設備往往初始成本較高，這可能會限制其在價格敏感型市場和發展中市場的普及。

新冠疫情的影響

新冠疫情擾亂了醫療服務，導致許多常規預約和非緊急手術被推遲。供應鏈中斷也影響了某些醫療設備的供應。然而，疫情也激發了人們對居家疾病管理和遠端監測的濃厚興趣。這反過來又推動了對互聯糖尿病技術的需求，並進一步凸顯了數位化醫療解決方案的重要性。

細分分析

按類型

從類型來看，市場可分為監測設備和治療設備。由於血糖值監測系統和連續血糖監測技術的廣泛應用，監測設備目前佔據了最大的市場佔有率。連續監測能夠提供即時訊息，並有助於提高患者的自我管理能力。

治療設備包括胰島素筆、胰島素幫浦、胰島素貼片和自動胰島素輸注系統。隨著患者尋求更便利、更個人化的胰島素給藥方式，先進的治療技術正日益受到關注。

透過分銷管道

市場區隔將市場分為醫療保健銷售和零售。由於糖尿病監測產品透過藥局和其他零售通路的普及，零售預計將實現強勁成長。同時，透過醫院、診所和醫療保健系統部署的先進醫療設備，其醫療保健銷售仍然十分可觀。

區域趨勢

北美洲

北美地區憑藉其高糖尿病盛行率、先進的醫療基礎設施、全面的保險覆蓋以及互聯監測和胰島素輸注技術的快速普及，在2025年繼續保持領先地位。此外，該地區還受益於主要製造商的聚集以及對糖尿病相關創新領域的大量投資。

歐洲

歐洲是一個成熟的市場，擁有健全的公共醫療體系和廣泛應用的先進糖尿病監測技術。糖尿病盛行率的上升和人們對疾病管理意識的提高預計將持續推動該地區的需求。

亞太地區

預計到 2034 年，亞太地區將經歷最快的成長。糖尿病盛行率上升、都市化加快、醫療基礎設施改善以及技術先進的監測和治療設備的日益普及，正在為中國、印度、日本和其他國家創造巨大的商機。

拉丁美洲、中東和非洲

在這些地區，由於診斷率的提高、醫療基礎設施的完善以及糖尿病管理意識的增強，市場預計將逐步擴大。對醫療系統投入的增加將有助於其長期普及。

感測器精度、小型化、互通性、人工智慧和自動胰島素輸注的創新將繼續是市場發展的核心。持續血糖監測和封閉回路型胰島素輸注系統蘊藏著巨大的成長潛力。隨著診斷和醫療保健服務的可近性不斷提高，新興市場也湧現出新的機會。能夠提供價格合理、連接便利、臨床療效顯著且易於使用的產品的公司，可望進一步增強其競爭優勢。

報告範圍

這份糖尿病醫療設備市場報告全面分析了市場規模、市場價值、成長要素、趨勢、限制因素、市場區隔、區域表現、競爭格局、技術發展和產業機會。報告評估了醫療保健和零售分銷管道中的監測和治療設備，並檢驗了全球主要地區的市場趨勢。

單價（10億美元）

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇

第4章：主要考慮因素

  • 主要國家糖尿病盛行率和發生率
  • 技術進步
  • 主要市場參與者/主要地區的價格分析
  • 近期產業趨勢，例如併購

第5章：2021-2034年全球糖尿病醫療設備市場分析、洞察與預測

  • 主要發現與總結
  • 市場分析、洞察與預測：按類型
    • 血糖值監測系統
      • 連續血糖監測系統
      • 自我監測血糖系統
    • 治療設備
      • 胰島素筆
      • 胰島素幫浦
      • 胰島素噴射注射器
      • 胰島素注射器
      • 其他
  • 市場分析、洞察與預測：按分銷管道分類
    • 向機構銷售
    • 零售銷售
  • 市場分析、洞察與預測：按地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美糖尿病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲糖尿病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 法國
    • 其他歐洲國家

第8章：亞太地區糖尿病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲糖尿病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲糖尿病醫療設備市場分析、洞察與預測（2021-2034年）

  • 國家
    • 南非
    • GCC
    • 其他中東和非洲國家

第11章 競爭分析

  • 主要行業趨勢
  • 全球市佔率分析（2021）
  • 公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Tandem Diabetes Care, Inc.
    • B. Braun Melsungen AG
    • Medtronic
    • BD
    • Novo Nordisk A/S
    • Abbott
    • Other Prominent Players

第12章 戰略建議

Product Code: FBI100803

Growth Factors of diabetes devices Market

The global diabetes devices market size was valued at USD 35.71 billion in 2025 and is projected to grow from USD 38.77 billion in 2026 to USD 74.73 billion by 2034, exhibiting a CAGR of 8.55% during the forecast period. North America dominated the market with a 40.54% share in 2025. The market is supported by the rising prevalence of diabetes, increasing demand for continuous disease management, technological advancements, and growing adoption of connected monitoring and insulin delivery solutions.

The diabetes devices market includes monitoring and treatment technologies that help patients and healthcare professionals manage diabetes more effectively. Blood glucose monitoring systems, continuous glucose monitoring devices, insulin pumps, insulin pens, and automated delivery systems are increasingly becoming important components of modern diabetes care. The shift from periodic monitoring toward continuous, connected, and personalized management is creating new opportunities for market expansion.

Market Definition and Scope

The diabetes devices market covers medical devices used for diabetes monitoring, diagnosis, treatment, and long-term disease management. The market is analyzed by type, distribution channel, and region. Increasing healthcare expenditure, improved diagnosis, wider reimbursement coverage, and rising awareness of diabetes management are expected to support market growth through 2034.

Market Dynamics

Drivers

Rising Prevalence of Diabetes

The increasing global prevalence of diabetes is a primary factor driving demand for monitoring and treatment devices. Rapid urbanization, sedentary lifestyles, obesity, and changing dietary patterns are contributing to the expanding diabetic population. Growing diagnosis rates are consequently increasing the need for blood glucose monitoring systems and insulin delivery technologies.

Introduction of Advanced Products

Continuous innovation is transforming diabetes management. Connected glucose monitors, smart insulin pumps, wearable devices, insulin patches, and automated insulin delivery platforms are improving patient convenience and treatment effectiveness. Integration with mobile applications and digital health platforms is further encouraging adoption.

Trends

The market is undergoing a shift toward digitalization, automation, and connected diabetes care. Continuous glucose monitoring is becoming an important technology because it provides frequent glucose readings and enables patients and clinicians to identify trends. Artificial intelligence, predictive analytics, cloud connectivity, and mobile applications are increasingly being incorporated into diabetes devices, supporting personalized and data-driven treatment.

Restraints

High development costs, stringent regulatory requirements, reimbursement limitations, and complex manufacturing processes can restrict market expansion. Advanced devices can also have higher upfront costs, which may limit adoption in price-sensitive and developing markets.

Impact of COVID-19

The COVID-19 pandemic disrupted healthcare services and delayed several routine consultations and non-emergency procedures. Supply-chain interruptions also affected the availability of certain medical devices. However, the pandemic increased interest in home-based disease management and remote monitoring. This supported demand for connected diabetes technologies and strengthened the importance of digital healthcare solutions.

Segmentation Analysis

By Type

Based on type, the market is divided into monitoring devices and treatment devices. Monitoring devices represented the leading category, supported by increasing adoption of blood glucose monitoring systems and continuous glucose monitoring technologies. Continuous monitoring offers real-time information and supports better patient self-management.

Treatment devices include insulin pens, insulin pumps, patches, and automated insulin delivery systems. Advanced treatment technologies are gaining traction as patients increasingly seek convenient and personalized methods of insulin administration.

By Distribution Channel

The market is segmented into institutional sales and retail sales. Retail sales are expected to experience strong growth due to the increasing availability of diabetes monitoring products through pharmacies and other retail channels. Institutional sales remain important for advanced devices adopted through hospitals, clinics, and healthcare systems.

Regional Insights

North America

North America maintained its leading position in 2025 due to high diabetes prevalence, advanced healthcare infrastructure, strong reimbursement coverage, and rapid adoption of connected monitoring and insulin delivery technologies. The region benefits from the presence of major manufacturers and significant investment in diabetes-related innovation.

Europe

Europe represents an established market supported by public healthcare systems and increasing adoption of advanced diabetes monitoring technologies. Rising diabetes prevalence and growing awareness of disease management are expected to sustain regional demand.

Asia Pacific

Asia Pacific is expected to register the fastest growth through 2034. Rising diabetes prevalence, urbanization, improving healthcare infrastructure, and increasing adoption of technologically advanced monitoring and treatment devices are creating significant opportunities across China, India, Japan, and other countries.

Latin America, Middle East & Africa

These regions are expected to experience gradual expansion as diagnosis rates improve, healthcare infrastructure develops, and awareness of diabetes management increases. Increasing investment in healthcare systems will support long-term adoption.

Competitive Landscape

The diabetes devices market is highly competitive, with leading companies focusing on product innovation, connected technologies, strategic partnerships, and geographic expansion. Key companies include F. Hoffmann-La Roche Ltd., Tandem Diabetes Care, Inc., B. Braun Melsungen AG, Medtronic, BD, Novo Nordisk A/S, Abbott, and Sanofi. Companies are increasingly developing integrated ecosystems combining hardware, software, analytics, and digital health services.

Innovation and Growth Opportunities

Innovation in sensor accuracy, miniaturization, interoperability, artificial intelligence, and automated insulin delivery will remain central to future market development. Continuous glucose monitoring and closed-loop insulin delivery systems offer significant growth potential. Emerging markets also provide opportunities as diagnosis and healthcare access improve. Companies capable of combining affordability, connectivity, clinical effectiveness, and ease of use are likely to strengthen their competitive position.

Report Coverage

The diabetes devices market report provides comprehensive analysis of market size, market value, growth drivers, trends, restraints, segmentation, regional performance, competitive landscape, technological developments, and industry opportunities. The report evaluates monitoring and treatment devices across institutional and retail distribution channels and examines developments across major global regions.

Conclusion

The global diabetes devices market is expected to expand from USD 35.71 billion in 2025 to USD 38.77 billion in 2026 and USD 74.73 billion by 2034. Rising diabetes prevalence, increasing demand for continuous monitoring, technological advancements, and the integration of devices with digital healthcare platforms will remain major growth factors. North America will continue to represent a strong market, while Asia Pacific is positioned as a major growth opportunity. The transition toward connected, automated, and personalized diabetes management is expected to define the industry's development through 2034.

Unit Value (USD billion)

Segmentation By Type

  • Blood Glucose Monitoring Systems
    • Continuous Glucose Monitoring Systems
    • Self-Monitoring Blood Glucose Systems
  • Treatment Devices
    • Insulin Pens
    • Insulin Pumps
    • Insulin Jet Injectors
    • Insulin Syringes
    • Others

By Distribution Channel

  • Institutional Sales
  • Retail Sales

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Prevalence and Incidence of Diabetes by Key Countries
  • 4.2. Technological Advancements
  • 4.3. Pricing Analysis, by Key Market Players/ Key Regions
  • 4.4. Recent Industry Developments Such As Mergers & Acquisitions

5. Global Diabetes Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast- By Type
    • 5.2.1. Blood Glucose Monitoring Systems
      • 5.2.1.1. Continuous Glucose Monitoring Systems
      • 5.2.1.2. Self-Monitoring Blood Glucose Systems
    • 5.2.2. Treatment Devices
      • 5.2.2.1. Insulin Pens
      • 5.2.2.2. Insulin Pumps
      • 5.2.2.3. Insulin Jet Injectors
      • 5.2.2.4. Insulin Syringes
      • 5.2.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast- By Distribution Channel
    • 5.3.1. Institutional Sales
    • 5.3.2. Retail Sales
  • 5.4. Market Analysis, Insights and Forecast- By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Diabetes Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis, Insights and Forecast - By Type
    • 6.2.1. Blood Glucose Monitoring Systems
      • 6.2.1.1. Continuous Glucose Monitoring Systems
      • 6.2.1.2. Self-Monitoring Blood Glucose Systems
    • 6.2.2. Treatment Devices
      • 6.2.2.1. Insulin Pens
      • 6.2.2.2. Insulin Pumps
      • 6.2.2.3. Insulin Jet Injectors
      • 6.2.2.4. Insulin Syringes
      • 6.2.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.3.1. Institutional Sales
    • 6.3.2. Retail Sales
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Diabetes Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis, Insights and Forecast - By Type
    • 7.2.1. Blood Glucose Monitoring Systems
      • 7.2.1.1. Continuous Glucose Monitoring Systems
      • 7.2.1.2. Self-Monitoring Blood Glucose Systems
    • 7.2.2. Treatment Devices
      • 7.2.2.1. Insulin Pens
      • 7.2.2.2. Insulin Pumps
      • 7.2.2.3. Insulin Jet Injectors
      • 7.2.2.4. Insulin Syringes
      • 7.2.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.3.1. Institutional Sales
    • 7.3.2. Retail Sales
  • 7.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. Spain
    • 7.4.4. Italy
    • 7.4.5. Scandinavia
    • 7.4.6. France
    • 7.4.7. Rest of Europe

8. Asia Pacific Diabetes Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis, Insights and Forecast - By Type
    • 8.2.1. Blood Glucose Monitoring Systems
      • 8.2.1.1. Continuous Glucose Monitoring Systems
      • 8.2.1.2. Self-Monitoring Blood Glucose Systems
    • 8.2.2. Treatment Devices
      • 8.2.2.1. Insulin Pens
      • 8.2.2.2. Insulin Pumps
      • 8.2.2.3. Insulin Jet Injectors
      • 8.2.2.4. Insulin Syringes
      • 8.2.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.3.1. Institutional Sales
    • 8.3.2. Retail Sales
  • 8.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.4.1. China
    • 8.4.2. India
    • 8.4.3. Australia
    • 8.4.4. Japan
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Diabetes Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis, Insights and Forecast - By Type
    • 9.2.1. Blood Glucose Monitoring Systems
      • 9.2.1.1. Continuous Glucose Monitoring Systems
      • 9.2.1.2. Self-Monitoring Blood Glucose Systems
    • 9.2.2. Treatment Devices
      • 9.2.2.1. Insulin Pens
      • 9.2.2.2. Insulin Pumps
      • 9.2.2.3. Insulin Jet Injectors
      • 9.2.2.4. Insulin Syringes
      • 9.2.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.3.1. Institutional Sales
    • 9.3.2. Retail Sales
  • 9.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Diabetes Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis, Insights and Forecast - By Type
    • 10.2.1. Blood Glucose Monitoring Systems
      • 10.2.1.1. Continuous Glucose Monitoring Systems
      • 10.2.1.2. Self-Monitoring Blood Glucose Systems
    • 10.2.2. Treatment Devices
      • 10.2.2.1. Insulin Pens
      • 10.2.2.2. Insulin Pumps
      • 10.2.2.3. Insulin Jet Injectors
      • 10.2.2.4. Insulin Syringes
      • 10.2.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Distribution Channel
    • 10.3.1. Institutional Sales
    • 10.3.2. Retail Sales
  • 10.4. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.4.1. South Africa
    • 10.4.2. GCC
    • 10.4.3. Rest of Middle East and Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2021)
  • 11.3. Company Profiles
    • 11.3.1. F. Hoffmann-La Roche Ltd.
      • 11.3.1.1. Overview,
      • 11.3.1.2. Types & services,
      • 11.3.1.3. SWOT analysis,
      • 11.3.1.4. Recent developments,
      • 11.3.1.5. strategies,
      • 11.3.1.6. financials (based on availability)
    • 11.3.2. Tandem Diabetes Care, Inc.
      • 11.3.2.1. Overview,
      • 11.3.2.2. Types & services,
      • 11.3.2.3. SWOT analysis,
      • 11.3.2.4. Recent developments,
      • 11.3.2.5. strategies,
      • 11.3.2.6. financials (based on availability)
    • 11.3.3. B. Braun Melsungen AG
      • 11.3.3.1. Overview,
      • 11.3.3.2. Types & services,
      • 11.3.3.3. SWOT analysis,
      • 11.3.3.4. Recent developments,
      • 11.3.3.5. strategies,
      • 11.3.3.6. financials (based on availability)
    • 11.3.4. Medtronic
      • 11.3.4.1. Overview,
      • 11.3.4.2. Types & services,
      • 11.3.4.3. SWOT analysis,
      • 11.3.4.4. Recent developments,
      • 11.3.4.5. strategies,
      • 11.3.4.6. financials (based on availability)
    • 11.3.5. BD
      • 11.3.5.1. Overview,
      • 11.3.5.2. Types & services,
      • 11.3.5.3. SWOT analysis,
      • 11.3.5.4. Recent developments,
      • 11.3.5.5. strategies,
      • 11.3.5.6. financials (based on availability)
    • 11.3.6. Novo Nordisk A/S
      • 11.3.6.1. Overview,
      • 11.3.6.2. Types & services,
      • 11.3.6.3. SWOT analysis,
      • 11.3.6.4. Recent developments,
      • 11.3.6.5. strategies,
      • 11.3.6.6. financials (based on availability)
    • 11.3.7. Abbott
      • 11.3.7.1. Overview,
      • 11.3.7.2. Types & services,
      • 11.3.7.3. SWOT analysis,
      • 11.3.7.4. Recent developments,
      • 11.3.7.5. strategies,
      • 11.3.7.6. financials (based on availability)
    • 11.3.8. Other Prominent Players
      • 11.3.8.1. Overview,
      • 11.3.8.2. Types & services,
      • 11.3.8.3. SWOT analysis,
      • 11.3.8.4. Recent developments,
      • 11.3.8.5. strategies,
      • 11.3.8.6. financials (based on availability)

12. Strategic Recommendations

List of Tables

  • Table 1: Global Diabetes Devices Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 2: Global Diabetes Devices Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034
  • Table 3: Global Diabetes Devices Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
  • Table 4: North America Diabetes Devices Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 5: North America Diabetes Devices Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034
  • Table 6: North America Diabetes Devices Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
  • Table 7: Europe Diabetes Devices Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 8: Europe Diabetes Devices Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034
  • Table 9: Europe Diabetes Devices Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Diabetes Devices Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 11: Asia Pacific Diabetes Devices Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034
  • Table 12: Asia Pacific Diabetes Devices Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Diabetes Devices Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 14: Latin America Diabetes Devices Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034
  • Table 15: Latin America Diabetes Devices Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Diabetes Devices Market Revenue (US$ Mn) Forecast, by Type, 2021-2034
  • Table 17: Middle East & Africa Diabetes Devices Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2021-2034
  • Table 18: Middle East & Africa Diabetes Devices Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Diabetes Devices Market Revenue Breakdown (US$ Mn, %) by Region, 2021 & 2034
  • Figure 2: Global Diabetes Devices Market Value Share (%), by Type, 2021 & 2034
  • Figure 3: Global Diabetes Devices Market Forecast (US$ Mn), by Blood Glucose Monitoring Systems, 2021-2034
  • Figure 4: Global Diabetes Devices Market Forecast (US$ Mn), by Treatment Devices, 2021-2034
  • Figure 5: Global Diabetes Devices Market Value Share (%), by Distribution Channel, 2021 & 2034
  • Figure 6: Global Diabetes Devices Market Forecast (US$ Mn), by Institutional Sales, 2021-2034
  • Figure 7: Global Diabetes Devices Market Forecast (US$ Mn), by Retail Sales, 2021-2034
  • Figure 8: Global Diabetes Devices Market Value (US$ Mn), by Region, 2021 & 2034
  • Figure 9: North America Diabetes Devices Market Value (US$ Mn), by Type, 2021 & 2034
  • Figure 10: North America Diabetes Devices Market Value Share (%), by Type, 2021
  • Figure 11: North America Diabetes Devices Market Value (US$ Mn), by Treatment Devices, 2021 & 2034
  • Figure 12: North America Diabetes Devices Market Value Share (%), by Treatment Devices, 2021
  • Figure 13: North America Diabetes Devices Market Value (US$ Mn), by Distribution Channel, 2021 & 2034
  • Figure 14: North America Diabetes Devices Market Value Share (%), by Distribution Channel, 2021
  • Figure 15: North America Diabetes Devices Market Value (US$ Mn), By Country, 2021 & 2034
  • Figure 16: North America Diabetes Devices Market Value Share (%), By Country, 2021
  • Figure 17: Europe Diabetes Devices Market Value (US$ Mn), by Type, 2021 & 2034
  • Figure 18: Europe Diabetes Devices Market Value Share (%), by Type, 2021
  • Figure 19: Europe Diabetes Devices Market Value (US$ Mn), by Treatment Devices, 2021 & 2034
  • Figure 20: Europe Diabetes Devices Market Value Share (%), by Treatment Devices, 2021
  • Figure 21: Europe Diabetes Devices Market Value (US$ Mn), by Distribution Channel, 2021 & 2034
  • Figure 22: Europe Diabetes Devices Market Value Share (%), by Distribution Channel, 2021
  • Figure 23: Europe Diabetes Devices Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 24: Europe Diabetes Devices Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 25: Asia Pacific Diabetes Devices Market Value (US$ Mn), by Type, 2021 & 2034
  • Figure 26: Asia Pacific Diabetes Devices Market Value Share (%), by Type, 2021
  • Figure 27: Asia Pacific Diabetes Devices Market Value (US$ Mn), by Treatment Devices, 2021 & 2034
  • Figure 28: Asia Pacific Diabetes Devices Market Value Share (%), by Treatment Devices, 2021
  • Figure 29: Asia Pacific Diabetes Devices Market Value (US$ Mn), by Distribution Channel, 2021 & 2034
  • Figure 30: Asia Pacific Diabetes Devices Market Value Share (%), by Distribution Channel, 2021
  • Figure 31: Asia Pacific Diabetes Devices Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 32: Asia Pacific Diabetes Devices Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 33: Latin America Diabetes Devices Market Value (US$ Mn), by Type, 2021 & 2034
  • Figure 34: Latin America Diabetes Devices Market Value Share (%), by Type, 2021
  • Figure 35: Latin America Diabetes Devices Market Value (US$ Mn), by Treatment Devices, 2021 & 2034
  • Figure 36: Latin America Diabetes Devices Market Value Share (%), by Treatment Devices, 2021
  • Figure 37: Latin America Diabetes Devices Market Value (US$ Mn), by Distribution Channel, 2021 & 2034
  • Figure 38: Latin America Diabetes Devices Market Value Share (%), by Distribution Channel, 2021
  • Figure 39: Latin America Diabetes Devices Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 40: Latin America Diabetes Devices Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 41: Middle East & Africa Diabetes Devices Market Value (US$ Mn), by Type, 2021 & 2034
  • Figure 42: Middle East & Africa Diabetes Devices Market Value Share (%), by Type, 2021
  • Figure 43: Middle East & Africa Diabetes Devices Market Value (US$ Mn), by Treatment Devices, 2021 & 2034
  • Figure 44: Middle East & Africa Diabetes Devices Market Value Share (%), by Treatment Devices, 2021
  • Figure 45: Middle East & Africa Diabetes Devices Market Value (US$ Mn), by Distribution Channel, 2021 & 2034
  • Figure 46: Middle East & Africa Diabetes Devices Market Value Share (%), by Distribution Channel, 2021
  • Figure 47: Middle East & Africa Diabetes Devices Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 48: Middle East & Africa Diabetes Devices Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 49: Global Diabetes Devices Market Share (%), By Company, 2021